Skip to main content
OpenTrials

Clinical trial condition

Non-Small-Cell Lung Carcinoma NSCLC

Explore clinical trials studying Non-Small-Cell Lung Carcinoma NSCLC. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Non-Small-Cell Lung Carcinoma NSCLC trial results

Active, Not Recruiting

Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)

NCT02453282

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Scottsdale, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Yuma, Arizona, United States
  • Research Site Bakersfield, California, United States
View all 196 locations
View Trial Details

Related conditions